JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).

IF 1.7 4区医学 Q3 HEMATOLOGY

International Journal of Hematology Pub Date : 2024-11-26 DOI:10.1007/s12185-024-03865-2

Naoto Takahashi, Katsuto Takenaka, Noriyoshi Iriyama, Keita Kirito, Tatsuya Kawaguchi, Shinya Kimura, Kazuya Shimoda

引用次数: 0

查看原文本刊更多论文

2023年JSH血液恶性肿瘤实用指南：白血病-4。慢性髓性白血病（CML）/骨髓增生性肿瘤（MPN）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Hematology 医学-血液学

CiteScore

3.90

自引率

4.80%

发文量

223

审稿时长

6 months

期刊介绍： The International Journal of Hematology, the official journal of the Japanese Society of Hematology, has a long history of publishing leading research in hematology. The journal comprises articles that contribute to progress in research not only in basic hematology but also in clinical hematology, aiming to cover all aspects of this field, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. The expanded [Progress in Hematology] section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. Reports on results of clinical trials are also included, thus contributing to the aim of fostering communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.